N@N

OSI Systems Receives $1.2 Million Order in the United Kingdom to Upgrade Patient Monitoring Systems

_{//science-technology.news-articles.net/content/2 .. ngdom-to-upgrade-patient-monitoring-systems.html}
^{Published in Science and Technology on Monday, December 20th 2010 at 5:06 GMT by Market Wire}  

HAWTHORNE, Calif.--([ BUSINESS WIRE ])--[ OSI Systems, Inc. ] (NASDAQ:OSIS), a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has received an order for approximately $1.2 million from a prominent hospital in the United Kingdom for an enterprise wide replacement program of their patient monitoring systems, which includes all departments across the care process from the ER to the ICU.

"We are excited about the opportunity to provide our latest series of Ultraview SL bedside monitors, central stations and the ICS G2 information system as we support the hospitala™s mission to deliver a comprehensive range of healthcare solutions to the community."

OSI Systems CEO Deepak Chopra, stated, aWe are excited about the opportunity to provide our latest series of Ultraview SL bedside monitors, central stations and the ICS G2 information system as we support the hospitala™s mission to deliver a comprehensive range of healthcare solutions to the community.a

About OSI Systems, Inc.

OSI Systems, Inc. is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications in the homeland security, healthcare, defense and aerospace industries. We combine more than 30 years of electronics engineering and manufacturing experience with offices and production facilities in more than a dozen countries to implement a strategy of expansion into selective end product markets. For more information on OSI Systems Inc. or any of its subsidiary companies, visit [ www.osi-systems.com ]. News Filter: OSIS-G

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the company's expectations, goals or intentions about the future, including, the Company's contracts to deliver a broad range of solutions to customers in the healthcare industry. The actual results may differ materially from those described in or implied by any forward-looking statement.